3-(TRIFLUOROMETHYL)IMIDAZO[1,5-A]PYRAZINE, 95.0%, 1g

2-Aminocyclohexanol, 97.0%, 10g

(3,5-Dimethyl-isoxazol-4-yl)-acetic acid, 95.0%, 5g

3-Methyl-4-hydroxypyridine, 95.0%, 250mg

(2S)-3-methyl-2-(N-{[2'-(1H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}pentanamido)butanoic acid, 97%, 500g

GC-Kapillarsäule ROTI®Cap-1, unpolar, L 15 m, Ø-Innen 0,32 mm, Filmd. 0,25 µm, 1 Stück

5-Bromo-4-methylpyridine-2-carboxylic acid, 95.0%, 10g

5-Bromo-2-(difluoro(3,4,5-trifluorophenoxy)methyl)-1,3-difluorobenzene, 98%, 25g

4-(4-Chlorophenyl)piperidine-4-carbonitrile, 95.0%, 100mg

2,4-Dimethylimidazole, 97.0%, 100g

6-Methyl-2-p-tolyl-imidazo[1,2-a]pyridine, 97.0%, 1g

Quercetin Dihydrat, min. 95 %, 100 g, kunststoffverpackung.

2-Hydroxy-4,6-dimethylpyrimidine, 95.0%, 100g